期刊文献+

DWI评价乳腺浸润性导管癌生物学特征 被引量:11

DWI in evaluation on biological characteristics of breast invasive ductal carcinoma
下载PDF
导出
摘要 目的探讨DWI评估乳腺浸润性导管癌(IDC)生物学特征的价值。方法回顾性分析经手术病理证实的87个乳腺浸润性导管癌的DWI数据,测量ADC值,评价并比较ADC值在不同腋窝淋巴结状态、组织学级别及分子学分型间的差异,并分析ADC值与腋窝淋巴结状态、组织学级别及分子学分型的相关性。结果淋巴结阳性病灶ADC值低于淋巴结阴性病灶(P=0.035),高级别乳腺癌ADC值低于中级别、低级别乳腺癌(P=0.021、0.002),ADC值在不同分子分型间差异无统计学意义。ADC值与组织学分级呈低度负相关(r_s=-0.357,P=0.001),与腋窝淋巴结转移及分子分型呈弱的负相关(r_s=-0.227,P=0.034;r_s=-0.093,P<0.001)。结论 DWI能够反映乳腺浸润性导管癌的生物学特征。 Objective To evaluate the value of DWI in assessing the biological characteristics of breast invasive ductal carcinoma(IDC).Methods Eighty-seven IDC lesions confirmed by postoperative pathology were involved in this retrospective study.The ADC values of IDC were compared among different lymph node status,grades,and molecular subtype.The correlations of ADC value and lymph node status,grades,and molecular subtype were evaluated.Results The ADC value of IDC with positive lymph node was lower than that with negative lymph node(P=0.035),and the ADC value of the high grade IDC was lower than those of medium grade IDC and low grade IDC(P=0.021,0.002).There was no significant difference of ADC value between different molecular subtypes.There was low negative correlation of ADC value with grades(rs=-0.357,P=0.001)and week negative correlation of ADC value lymph node status and nolecular subtype(rs=-0.227,P=0.034;rs=-0.093,P0.001).Conclusion DWI can provide useful information in evaluating the biological characteristics of IDC.
出处 《中国医学影像技术》 CSCD 北大核心 2017年第8期1232-1236,共5页 Chinese Journal of Medical Imaging Technology
基金 辽宁省科技计划项目(2013225021)
关键词 乳腺肿瘤 磁共振成像 弥散加权成像 表观弥散系数 Breast neoplasms Magnetic resonace imaging Diffusion weighted imaging Apparent diffusion coefficient
  • 相关文献

参考文献3

二级参考文献52

  • 1张瑰红,施达仁,梁晓曼,侯景辉,康苏娅,朱卫东,李晓兵,邵云,陈丽荣,周燕.显色原位杂交和免疫组织化学检测乳腺癌HER2/neu基因状况和蛋白表达的对照性研究[J].中华病理学杂志,2006,35(10):580-583. 被引量:29
  • 2<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:164
  • 3全国肿瘤防治研究办公室,卫生部卫生信息中心.中国试点市、县恶性肿瘤的发病与死亡(1993-1997).北京:中国医药科技出版社,2002.
  • 4Stewart BW,Kleihues P. World cancer report. IARC Press,Lyon,2003.
  • 5Althuis MD, Dozier JM, Anderson WF, et al. Global trends inbreast cancer incidence and mortality 197-1997. Int J Epidemiol,2005,34(2):405-412.
  • 6郝捷,赵平,陈万青.2011中国肿瘤登记年报.北京:军事医学科学出版社,2012.
  • 7陈竺.全国第三次死因回顾滿样调查报告.北京:中国协和医科大学出版社,2008.
  • 8Ferlay J,Shin HR,Bray F,et al. GLOBOCAN 2008 vl.2,CancerIncidence and Mortality Worldwide : IARC CancerBase No. 10[internet]. Lyon, France: International Agency for Research onCancer; 2010. Available from: http://glofiocan.iarc.fr,accessedon 30/10/2011.
  • 9Yang L,Parkin DM,Ferlay J,et al. Estimates of cancer incidencein China for 2000 and projections for 2005. Cancer EpidemiolBiomarkers Prev,2005,14(1) :243-250.
  • 10Zhao P, Dai M, Chen WQ, et al. Cancer trends in China. Jpn JClin Oncol,2010,40:281-285.

共引文献617

同被引文献64

引证文献11

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部